Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Total Liabilities 2017–2025
Aquestive Therapeutics Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aquestive Therapeutics Inc. total liabilities as of December 31, 2025: 194.1M, a 20.12% increase year-over-year.
- Aquestive Therapeutics Inc. total liabilities for 2025 were 194.1M, a 20.12% increase from 2024.
- Aquestive Therapeutics Inc. total liabilities for 2024 were 161.6M, a 1.42% decrease from 2023.
- Aquestive Therapeutics Inc. total liabilities for 2023 were 163.9M, a 6.67% decrease from 2022.
- Aquestive Therapeutics Inc. total liabilities for 2022 were 175.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aquestive Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $194 |
| 2024 | $162 |
| 2023 | $164 |
| 2022 | $176 |
| 2021 | $144 |
| 2020 | $111 |
| 2019 | $85 |
| 2018 | $77 |
| 2017 | $70 |
Aquestive Therapeutics Inc. Total Liabilities — FAQ
Aquestive Therapeutics Inc. (AQST) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's total liabilities history?
The chart and table above show Aquestive Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.